Copyright
©The Author(s) 2016.
World J Transplant. Dec 24, 2016; 6(4): 697-702
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Published online Dec 24, 2016. doi: 10.5500/wjt.v6.i4.697
Variable | Hazard ratio | 95%CI | P-value |
CNI tacrolimus | 0.6 | 0.45-0.79 | < 0.001 |
Retransplant | 1.43 | 0.91-2.24 | 0.123 |
PRA | 1 | 0.99-1.00 | 0.529 |
Cytolytic induction | 0.5 | 0.36-0.69 | < 0.001 |
- Citation: Kamel M, Kadian M, Srinivas T, Taber D, Posadas Salas MA. Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine. World J Transplant 2016; 6(4): 697-702
- URL: https://www.wjgnet.com/2220-3230/full/v6/i4/697.htm
- DOI: https://dx.doi.org/10.5500/wjt.v6.i4.697